Risk factors for the development of diabetic nephropathy
Introduction. Results of epidemiological analysis show that one third of patients with diabetes mellitus develop diabetic nephropathy (DN). Strategies used until now to slow down the progression of DN were initiated when the symptoms of DN were already present. Objective. Our objective was to analyz...
Príomhchruthaitheoirí: | Antić Miodrag, Jotić Aleksandra, Radović Milan, Seferović Jelena P., Lalić Nebojša M., Jovanović Dijana, Ležaić Višnja |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Serbian Medical Society
2009-01-01
|
Sraith: | Srpski Arhiv za Celokupno Lekarstvo |
Ábhair: | |
Rochtain ar líne: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2009/0370-81790902018A.pdf |
Míreanna comhchosúla
Míreanna comhchosúla
-
Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
de réir: Andrzej Konieczny, et al.
Foilsithe / Cruthaithe: (2021-09-01) -
Diabetic nephropathy in type 2 diabetes: the frequency and risk factors
de réir: Marijana Kovačević, et al.
Foilsithe / Cruthaithe: (2019-12-01) -
Immunoglobulin A-nephropathy: modern view of the problem and treatment options
de réir: I. T. Murkamilov, et al.
Foilsithe / Cruthaithe: (2021-06-01) -
Secondary Publication: Clinical Grade of IgA Nephropathy
de réir: Takahito Moriyama, et al.
Foilsithe / Cruthaithe: (2020-03-01) -
Efficacy and safety of Kunxian in IgA nephropathy
de réir: Yang Yang, et al.
Foilsithe / Cruthaithe: (2025-03-01)